CKPT(Delisted)
Checkpoint (CKPT) Stock Statistics, Valuation & Financial Metrics
Total Valuation
Checkpoint market cap is -- and enterprise value is --.
Share Statistics
Checkpoint has 87.02M shares outstanding, with a free float of 74.14M.
Valuation Ratios
Checkpoint's PE ratio is --, PB ratio is --, and PS ratio is --, showing whether the stock looks expensive or cheap.
Solvency
Checkpoint debt-to-equity ratio is 0 and debt-to-assets ratio is 0.52.
Liquidity
Checkpoint's current ratio is 1.91, quick ratio is 1.91, and cash ratio is 1.85, showing its short-term liquidity position.
Return on Capital
Checkpoint's ROE is -1869.55%, ROA is -244.94%, and ROIC is -1865.18%, showing its return on capital profile.
Profitability
Checkpoint gross margin is --, operating margin is --, and net margin is --.
Operating Efficiency
Checkpoint's asset turnover is --, inventory turnover is --, and receivables turnover is --, indicating its operating efficiency.
Income Statement
Checkpoint's revenue is --, gross profit is --, net income is -56.51M, and EBITDA is --.
Balance Sheet
Checkpoint's total debt is 0, net debt is 0, total equity is 16.30M, and cash is 33.04M.
Cash Flow Statement
Checkpoint's operating cash flow is -36.31M, free cash flow is -36.31M, and CapEx is --.
Dividends & Yields
Checkpoint dividend yield is --, with a payout ratio of -- and dividend per share of --.
Analyst Rating
Checkpoint's latest analyst rating is Unrate, with an analyst target price of --.
Company Info
A clinical-stage immunotherapy and targeted oncology company that developing treatments for solid tumor cancers
Per Share Metrics
Checkpoint's EPS is -1.28, book value per share is 0.19, and free cash flow per share is --.
